carlisle & Associates
generic drug updates News contact carlisle medical
generic drug updates
Launch of Generic Exalgo® Extended Release Tablets
Released: 05/19/2014
By: Carl Richie, Pharmacy Manager

The generic equivalent of Exalgo® extended release tablets (hydromorphone hydrochloride) has just been released, following FDA approval. Exalgo® is prescribed to treat moderate to severe pain.

Generic prescription drugs approved by the FDA have the same high quality and strength as brand-name drugs. Generic prescription drug manufacturing and packaging sites must pass the same quality standards as those of brand-name drugs.

Over the next 30 days, Carlisle Medical will be contacting physicians to inform them that the generic version of Exalgo® (hydromorphone hydrochloride) is available. Management is our focus as we are deeply involved in evaluating generic usage, as well as alternative therapies. We provide this on an ongoing basis through our Prescription Review service.

If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at

Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer